← Open Payments lookup

SHEYLA RANDLE: Open Payments

NPI 1992292528 · PEARLAND, TX. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$939 in 58 payments from 14 companies in 2025. Trend: 2023 $802 · 2024 $929 · 2025 $939

Food & beverage: $939
CompanyPaymentsAmount
ABBVIE INC.19$216
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)12$153
Alkermes, Inc.6$110
Neurocrine BioSciences, Inc.4$98
E.R. Squibb & Sons, L.L.C.3$68
Otsuka America Pharmaceutical, Inc.3$60
Vanda Pharmaceuticals Inc.2$43
Supernus Pharmaceuticals, Inc.2$39
Neos Therapeutics, LP2$34
Axsome Therapeutics, Inc.1$33

Products named: VRAYLAR, CAPLYTA, ARISTADA, INGREZZA, REXULTI, COBENFY, FANAPT, Qelbree.

Industry payments across TX — which companies pay providers there.